With respect to risks, GLP-1RA use was significantly associated with an increased risk of gastrointestinal disorders, hypotension, syncope, arthritic disorders, drug-induced pancreatitis, and other ...
Topline data were announced from a phase 3 trial evaluating ecopipam in pediatric and adult patients with Tourette syndrome.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback